Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized type 2 diabetes and obesity treatment, but many carry an FDA boxed warning regarding thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)
Patients taking Wegovy, particularly those with a history of eye issues, should engage in regular eye exams to monitor and manage potential eye-related side effects
The Serious CV Events primary endpoint was a composite of cardiovascular death (sudden and nonsudden cardiac death, fatal myocardial infarction, and fatal stroke) and nonfatal cardiovascular events (nonfatal myocardial infarction, peripheral vascular disease leading to amputation, and nonfatal stroke)
The decision to use compounded drugs is guided by the licensed provider's medical judgment, informed by a telehealth consultation and medical history." altRx also states that patients may receive medication that looks different than what is portrayed on the website
They also see these drugs as the best choices for lowering glucose and helping with weight loss
Comprehensive Medical Oversight Every patient in our GLP-1 Longevity Program receives: Thorough medical evaluation and baseline testing Personalized dosing protocols based on individual needs Regular monitoring of metabolic markers Ongoing support and dose adjustments as needed Integration with lifestyle optimization strategies Minimal Side Effects with Maximum Benefits Dr
